Showing results (1-10 of 8,539) with videos related to
Sort By:
Pageof 854
Journal of Biopharmaceutical Statistics|November 11, 2025
Tables, listings and figures in a clinical study report - quality or quantity?Ning Li, Yaohua Zhang, Naitee TingTherapeutic Innovation & Regulatory Science|May 2, 2018
Statistical Interactions in a Clinical TrialNaitee TingFrontiers in Public Health|January 17, 2014
An Application of Graphical Approach to Construct Multiple Testing Procedures in a Hypothetical Phase III DesignBushi Wang, Naitee TingJournal of Biopharmaceutical Statistics|July 24, 2026
Why the minimum effective dose is unidentifiable - and how a DOR→OOD standard delivers label-ready dosing in oncologyHaitao Pan, Naitee TingJournal of Biopharmaceutical Statistics|February 17, 2016
Sample size determination with familywise control of both type I and type II errors in clinical trialsBushi Wang, Naitee TingPharmaceutical Statistics|June 21, 2012
A proof-of-concept clinical trial design combined with dose-ranging explorationXin Wang, Naitee TingJournal of Biopharmaceutical Statistics|March 8, 2018
Bayesian sample size determination for a Phase III clinical trial with diluted treatment effectYing-Ying Zhang, Naitee TingStatistics in Medicine|May 20, 2003
A modified large-sample approach to approximate interval estimation for a particular intraclass correlation coefficientJoseph C Cappelleri, Naitee TingStatistics in Medicine|June 22, 2018
Dynamic development paths for expanding a proof-of-concept study to explore dose rangeQiqi Deng, Xiaofei Bai, Naitee TingCardiology and Therapy|October 7, 2016
A Prospective, Randomized, Open-Label Study to Evaluate Two Management Strategies for Gastrointestinal Symptoms in Patients Newly on Treatment with DabigatranDaniel O'Dea, Jacqueline Whetteckey, Naitee TingPageof 854